A Phase 2a Study of LLX-424 in Patients With a History of Kidney Stones
Clinical trial NCT06932146 · COMPLETED
Trial details
- NCT number
- NCT06932146
- Sponsor
- Lilac Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-23
- Primary completion
- 2025-09-30
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.